| dc.contributor.author | Selcukbiricik, F. | |
| dc.contributor.author | Yildiz, O. | |
| dc.contributor.author | Tural, D. | |
| dc.contributor.author | Ozturk, M. A. | |
| dc.contributor.author | Demir, G. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Serdengecti, S. | |
| dc.date.accessioned | 2019-08-13T12:10:23Z | |
| dc.date.accessioned | 2019-08-13T16:04:01Z | |
| dc.date.available | 2019-08-13T12:10:23Z | |
| dc.date.available | 2019-08-13T16:04:01Z | |
| dc.date.issued | 2011 | |
| dc.identifier.issn | 0959-8049 | |
| dc.identifier.uri | https://dx.doi.org/10.1016/S0959-8049(11)71665-3 | |
| dc.identifier.uri | http://hdl.handle.net/11446/3215 | |
| dc.description | European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care -- SEP 23-27, 2011 -- Stockholm, SWEDEN | en_US |
| dc.description | WOS: 000295752801391 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | ELSEVIER SCI LTD | en_US |
| dc.identifier.doi | 10.1016/S0959-8049(11)71665-3 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab? | en_US |
| dc.type | conferenceObject | en_US |
| dc.relation.journal | EUROPEAN JOURNAL OF CANCER | en_US |
| dc.department | DBÜ | en_US |
| dc.identifier.volume | 47 | en_US |
| dc.identifier.startpage | S397 | en_US |
| dc.identifier.endpage | S397 | en_US |
| dc.contributor.authorID | 0000-0003-1365-7944 | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.department-temp | [Selcukbiricik, F. -- Yildiz, O. -- Tural, D. -- Ozturk, M. A. -- Ozguroglu, M. -- Erdamar, S. -- Buyukunal, E. -- Mandel, N. M. -- Serdengecti, S.] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey -- [Demir, G.] Bilim Univ, Fac Med, Istanbul, Turkey | en_US |
